[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350139-105":59,"doc-detail-350139-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","development-of-cd-metal-organic-frameworks-loaded-with-olaparib-a-novel-approach-for-the-treatment-of-cervical-cancer","Development of β-CD metal organic frameworks loaded with olaparib - a novel approach for the treatment of cervical cancer","","β-CD metal organic frameworks (βCD-MOFs) with high porosity were synthesized and used to encapsulate olaparib (OP) to improve cervical-cancer treatment efficacy. OP-loaded βCD-MOFs were characterized by TC-1 cell-line studies and analytical techniques including FTIR, DSC, TGA, PXRD, SEM, and in vitro release assays. Encapsulation reached 76.48% and drug release remained sustained for 24 h. Compared with free OP, treated TC-1 cells showed reduced viability and lower IC50 (13.52 nM), along with elevated p53 and caspase-9, indicating effective apoptosis and therapeutic promise.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-cd-metal-organic-frameworks-loaded-with-olaparib-a-novel-approach-for-the-treatment-of-cervical-cancer/350139/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-cd-metal-organic-frameworks-loaded-with-olaparib-a-novel-approach-for-the-treatment-of-cervical-cancer/350139.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were βCD-MOFs prepared and how was olaparib loaded for cervical cancer therapy?","Question",{"text":113,"@type":114},"β-CD metal organic frameworks were synthesized with high porosity, then olaparib was successfully loaded into the βCD-MOFs. The study aimed to enhance olaparib efficacy through encapsulation and controlled release.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which characterization and biological evaluation methods were used to assess the OP-loaded βCD-MOFs?",{"text":118,"@type":114},"The OP-loaded βCD-MOFs were evaluated using FTIR, DSC, TGA, PXRD, SEM, and in vitro release studies. Biological performance in TC-1 cells included drug encapsulation assessment and an MTT assay, with related studies such as cytotoxicity and signaling changes.",{"name":120,"@type":111,"acceptedAnswer":121},"What biological effects were observed in TC-1 cells treated with OP-loaded βCD-MOFs compared with free olaparib?",{"text":122,"@type":114},"OP-loaded βCD-MOFs reduced cell viability more strongly than free OP and lowered the inhibitory concentration IC50 to 13.52 nM. They also increased p53 and caspase-9 levels, consistent with effective apoptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350139,1790854867,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDevelopment of β-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer  \nBader B. Alsulays1, Md. KhalidAnwer1􀀍, Muhannad N. Hatata1 & Mohammad Raish2  \nIn the current study, a highly porous β-CD-metal organic frameworks (βCD-MOFs) was prepared and drug, olaparib (OP) was loaded successfully in order to enhance the efficacy of OP for the treatment of cervical cancer. The produced OP-loaded βCD-MOFs were assessed using TC-1 cell lines for drug encapsulation, FTIR, DSC, TGA, PXRD, in vitro release studies, SEM, and MTT assay. βCD-MOFs successfully encapsulated the OP with a high efficiency of 76.48%, due to structural advantages of βCD-MOFs. In-vitro release studies exhibited a sustained release pattern for 24 h. As compared to freeOP, we observed a significant reduction in cell viability and lowered inhibitory concentration IC50 (13.52 nM) in TC-1 cells treated with OP-loaded βCD-MOFs. Additionally, p53 and caspase 9 were elevated by the OP-loaded βCD-MOFs, suggesting an effective apoptosis that may hold promise for the therapy of cervical cancer. Overall, OP-loaded βCD-MOFs could be alternative to conventional formulation of OPin treating cervical cancer.  \nKeywords Olaparib, Cyclodextrin, Metal organic frameworks, Caspase-9, Cervical cancer  \nCervical cancer remains one of the leading global health burdens affecting women, with significant morbidity and mortality rates particularly prevalent in low-and middle-income countries1,2. The main cause of cervical cancer is infection with specific high-risk human papillomavirus (HPV) strains3,4. Current standard treatments for cervical cancer typically involve surgery, radiation therapy, and chemotherapy, often in combination depending on the stage and location of the cancer5–7. While conventional chemotherapeutic agents like cisplatin and paclitaxel have been foundational in treating cervical cancer, these treatments exhibit significant limitations, notably their non-specific targeting, which damages healthy cells and leads to pronounced adverse effects, including nausea, nephrotoxicity, hematologic toxicity, and cardiotoxicity8,9.  \nOlaparib (OP), a potent poly (ADP-ribose) polymerase (PARP) inhibitor, has demonstrated substantial clinical effectiveness in treating various cancers, particularly those associated with DNA repair deficiencies, such as ovarian and breast cancers10, 11. Recent studies have suggested potential effectiveness of OP in cervical cancer, particularly in patients exhibiting homologous recombination repair deficiencies (HRD), a common trait in advanced cervical carcinomas12, 13. However, the clinical application of OP faces challenges including limited bioavailability, rapid systemic clearance, and substantial off-target effects. Hence, encapsulating OP in a targeted, controlled-release carrier system represents a significant advancement towards addressing these challenges and optimizing therapeutic outcomes14, 15.  \nThe approaches to improve the solubility and bioavailability of olaparib including amorphous solid dispersion16, nanocrystallization14, polymeric nanoparticles15, and self-emulsifying drug delivery systems (SEDDS)17 has been explored. Among these advancements, Cyclodextrin-based metal-organic frameworks (MOFs) have emerged as an innovative class of carriers due to their extraordinary porosity, tunable surface chemistry, exceptional biocompatibility, and responsiveness to the acidic microenvironment commonly found in tumor tissues16. The unique structural properties of β-cyclodextrins based MOFs, creating a platform that enhances the stability and bioavailability of therapeutic agents. Cyclodextrins’ innate capacity to create inclusion complexes makes them perfect for encapsulating a variety of drug molecules since it enhances solubility and provides regulated release profiles18–20.  \n1Department of Pharmaceutics, College ","cbCaifEc1ZyfDtQ7","https://ap.wps.com/l/cbCaifEc1ZyfDtQ7","pdf",2743038,"English","# Introduction\n# Background and Rationale\n# Objectives and Scope\n# Methodology\n## Materials\n## Cell culture\n## Synthesis of β-CD-K MOFs","[{\"question\":\"How were βCD-MOFs prepared and how was olaparib loaded for cervical cancer therapy?\",\"answer\":\"β-CD metal organic frameworks were synthesized with high porosity, then olaparib was successfully loaded into the βCD-MOFs. The study aimed to enhance olaparib efficacy through encapsulation and controlled release.\"},{\"question\":\"Which characterization and biological evaluation methods were used to assess the OP-loaded βCD-MOFs?\",\"answer\":\"The OP-loaded βCD-MOFs were evaluated using FTIR, DSC, TGA, PXRD, SEM, and in vitro release studies. Biological performance in TC-1 cells included drug encapsulation assessment and an MTT assay, with related studies such as cytotoxicity and signaling changes.\"},{\"question\":\"What biological effects were observed in TC-1 cells treated with OP-loaded βCD-MOFs compared with free olaparib?\",\"answer\":\"OP-loaded βCD-MOFs reduced cell viability more strongly than free OP and lowered the inhibitory concentration IC50 to 13.52 nM. They also increased p53 and caspase-9 levels, consistent with effective apoptosis.\"}]","Development of β-CD metal organic frameworks loaded with olaparib - a novel approach for the treatment of cervical cancer | PDF",1790087334,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8b012938947750ee323e59203271810.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f56959436963277fe17221e6b09e3c3.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70650dba954128cddc32369fa8d2ae27.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4570fe45b32c446b84375796e893c77a.webp",980,1287]